Recombinant Human Coagulation Factor IX Fc Fusion Protein Effective in Kids B-LONG Study

Article Figures & Data

Figures

  • Figure 1.

    Kids B-LONG Study Design

    ED, exposure day; FIX, factor IX; PK, pharmacokinetic; rFIXFc, recombinant factor IX Fc fusion protein.

    aA 96-hour washout period with no FIX treatment was required prior to administration of prestudy FIX, 28 ± 7 d prior to rFIXFc dosing at baseline, and prior to administration of rFIXFc on day 1; in younger children and subjects who required a second washout attempt, a 72-hour washout period was permitted.

    Reproduced with permission from K Fischer, MD, PhD.